Loading...
Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir
Tenofovir disoproxil fumarate (TDF) is widely used to treat hepatitis B virus (HBV) patients in the USA and Europe. No confirmed report of resistance selection during treatment with TDF in treatment-naïve and nucleoside/nucleotide analog-treated chronic hepatitis B patients has yet been reported. He...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4085295/ https://ncbi.nlm.nih.gov/pubmed/25061278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S65349 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|